Brazil Case study Oncology
Case Study – Oncology
ODC Turned Brazil into the World's #1 Country for a Biomarker-Selected Global Precision Oncology Trial (GIST)
ODC provides the ecosystem access that pharmaceutical sponsors need to recruit faster, retain more patients, and execute studies efficiently across key Latin American countries.
A purpose-built infrastructure connecting sponsors, physicians, research centers, and patients across the region.
Patient Identification
ODC works with a referral infrastructure that supports patient identification and trial awareness through treating physicians — reflecting how patients in the region typically learn about clinical trial opportunities.
validated physicians across Latin America
Infrastructure & Ecosystem
Research sites are prepared and trained for trial participation, with long-standing investigator relationships enabling faster activation timelines and more reliable study startup. ODC maintains relationships with medical societies, patient advocacy organizations, and regulatory stakeholders.
research sites across Brazil, Argentina, and Chile
Digital & In-Person Outreach
Our omnichannel recruitment approach integrates in-person visits, digital outreach and campaigns, physician referrals, and site-level engagement into a single, coordinated strategy, ensuring patients are reached at every step of their journey.
Strategic Partnerships
ODC maintains long-standing relationships with medical societies, patient advocacy organizations, and regulatory stakeholders across Latin America — enabling streamlined site activation, faster regulatory approvals, and deeper community trust.
End-to-end patient support
Dedicated patient support programs guide participants through the study journey — including scheduling coordination, education, and logistical assistance — contributing to strong retention and consistent engagement throughout the trial lifecycle.
420
260
80
65
47
LATAM shows
significantly lower trial
density — meaning less
competition for eligible
patients.
| Region | Trial Saturation | Naïve Access |
|---|---|---|
| United States |
Very high
|
Lower
|
| Western Europe |
High
|
Moderate
|
| Latin America |
Lower
|
Higher
|
Earlier-stage patient
populations across
multiple therapeutic
areas.
37%
Sites fail to enroll a single patient
<1
Avg. patients per site/month
2-3x
Faster enrollment in LATAM sites
Higher per-site
enrollment means fewer
sites needed and faster
timelines.
United States
$1.00
Latin America avg.
~$0.56
~44% lower operating
costs in LATAM vs. the
United States.
Regulatory modernization and optimized approval pathways
Argentina
Experienced research centers and structured ethical review processes
Chile
Stable regulatory oversight and strong clinical research infrastructure
Increasing ICH alignment
enables streamlined
multi-regional
submissions.
We enable access to clinical success in LATAM
Explore more clinical trial insights and case studies from across Latin America.
By submitting this form, you declare that you are aware that the personal data provided will be processed by ODC Life Sciences to receive, analyze, and respond to your request, make the necessary contacts, and, when applicable, comply with legal or regulatory obligations and exercise ODC’s rights.
When necessary for these purposes, the data may be shared with ODC Group companies and third parties involved in addressing the request, including service providers, partners, sponsors, or research centers, as applicable and in accordance with the principles and requirements set forth in the General Data Protection Law (Brazilian Law No. 13.709/2018 – LGPD).
ODC will adopt appropriate measures to protect the security and confidentiality of personal data and will retain it for the period necessary to fulfill the stated purposes and to comply with legal or regulatory obligations or for the regular exercise of rights.
For more information on the processing of personal data and on exercising the rights provided for in the LGPD (Brazilian General Data Protection Law), please consult the ODC Life Sciences Privacy Policy.
And add a mandatory checkbox for submitting the form, with the following phrase next to the checkbox: I have read and am aware of the Privacy Notice and Personal Data Processing Policy.